PMA device
Lap-Band Adjustable Gastric Banding System
Medtimo, Inc. · Implant, Intragastric For Morbid Obesity (LTI, Class III) · First FDA decision Jun 5, 2001, newest Dec 12, 2023Obesity
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
16
PMA pathway
Device trials
17
Naming "Lap-Band Adjustable Gastric"
MAUDE reports
94
Brand "Lap-Band Adjustable Gastric", since 2015
PubMed studies
9
Mentioning "Lap-Band Adjustable Gastric"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Lap-Band Adjustable Gastric Banding System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 16 decisions filed under this name.
- Lap-Band Adjustable Gastric Banding SystemPMA supplement
P000008-S048 · Decided Dec 12, 2023 · 201 days after receipt · Normal 180 Day Track
Device type: IMPLANT, INTRAGASTRIC FOR MORBID OBESITY (LTI) · GI, Urology & Nephrology
- Lap-Band Adjustable Gastric Banding SystemPMA supplement
P000008-S039 · Decided Oct 2, 2017 · 89 days after receipt · Normal 180 Day Track No User Fee
Device type: IMPLANT, INTRAGASTRIC FOR MORBID OBESITY (LTI) · GI, Urology & Nephrology
- LAP-BAND ADJUSTABLE GASTRIC BANDING SYSTEMPMA supplement
P000008-S037 · Decided Mar 28, 2016 · 59 days after receipt · Normal 180 Day Track No User Fee
Device type: IMPLANT, INTRAGASTRIC FOR MORBID OBESITY (LTI) · GI, Urology & Nephrology
3 more FDA decisions with a free account
Older decisions: P000008-S029, P000008-S028, P000008-S027, P000008-S023, P000008-S022, P000008-S019, P000008-S012, P000008-S009, P000008-S008, P000008
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Bariatric Surgery for the Treatment of Morbid Obesity - Facility Certification RequirementNational analysisReview closedCAG-00250R3Updated Sep 16, 2026
- Bariatric Surgery for the Treatment of Morbid ObesityNational analysisReview closedCAG-00250R2Updated Sep 16, 2026
- Bariatric Surgery for the Treatment of Morbid ObesityNational analysisReview closedCAG-00250RUpdated Sep 16, 2026
- Bariatric Surgery for Treatment of Co-Morbid Conditions Related to Morbid ObesityNational determinationOn the books100.1Updated Apr 9, 2025
- Bariatric Surgical Management of Morbid ObesityLocal determinationIn effectL35022Novitas Solutions, Inc.Updated May 7, 2021
- Surgical Management of Morbid ObesityLocal determinationIn effectL33411First Coast Service Options, Inc.Updated Oct 2, 2019
Clinical trials
Device studies on ClinicalTrials.gov that name "Lap-Band Adjustable Gastric", any status and sponsor, newest update first.
Kirk ReichardAcademic, hospital or other
NCT01619488 · 57 participants · Start Apr 23, 2007 · Primary completion Apr 4, 2016
Device: Adjustable Gastric Band · For: Morbid Obesity
Sites: Wilmington, Delaware
University Medical Center, KazakhstanAcademic, hospital or other
NCT04762849 · 0 participants · Start Apr 1, 2021 · Primary completion Apr 1, 2024
Device: A shape-memory ring for adjustable gastric banding · For: Obesity
Sites: Astana, Kazakhstan
NYU Langone HealthAcademic, hospital or other
NCT00587301 · 119 participants · Start Jun 2005 · Primary completion Jul 8, 2020
Device: Lap-Band · For: Obesity; DM
Sites: New York, New York
14 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Lap-Band Adjustable Gastric", and for the whole product code for context.
This brand
94 reports: 47 malfunction, 46 injury, 1 death
Whole product code LTI
5,233 reports: 2,779 malfunction, 2,372 injury, 70 death
Newest reports for this brand
APOLLO ENDOSURGERY COSTA RICA S. R. L.
MW5088910 · Received Aug 8, 2019 · Event dated Jul 1, 2019
Device type: Implant, Intragastric For Morbid Obesity (LTI)
Device problem as coded: Patient-Device Incompatibility
Patient problem as coded: Chest Pain; Pain; Vomiting; Burning Sensation
- LAP-BAND ADJUSTABLE GASTRIC BAND SYSTEMMalfunction
6438611 · Received Mar 28, 2017 · Event dated Apr 25, 2016
Device type: Implant, Intragastric For Morbid Obesity (LTI)
Device problem as coded: Device Operates Differently Than Expected
Patient problem as coded: Abdominal Pain; Heartburn/Indigestion; Weight Changes; Foreign Body In Patient
3006722112-2015-00374 · Received Sep 29, 2015 · Event dated Aug 22, 2015
Device type: Implant, Intragastric For Morbid Obesity (LTI)
Device problem as coded: Improper or Incorrect Procedure or Method
Patient problem as coded: Not Applicable
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2743-2018 · Started Nov 22, 2017
Reason given: Component of the Lap-Band system was missing from the package
Cause as FDA categorized it: Under Investigation by firm · Device type: Implant, Intragastric For Morbid Obesity (LTI)
Z-2123-2011 · Started Mar 21, 2011 · Posted by FDA May 2, 2011
Reason given: The recall was initiated because Allergan has determined that a number of Access Port Needle pouches from one specific lot number may have small gaps in a pouch seal. Consequently the product may no longer be sterile.
Cause as FDA categorized it: Pending · Device type: Implant, Intragastric For Morbid Obesity (LTI)
Z-0418-2011 · Started Sep 16, 2010 · Posted by FDA Nov 18, 2010
Reason given: In a LAP-BAND System adjustment, failure to inject the needle perpendicular to the access port septum, as described in Directions for Use, may lead to port damage, resulting in subsequent port leakage. Leakage results in deflation of the LAP-BAND to its widest, open position requiring a procedure to replace the port....
Cause as FDA categorized it: Pending · Device type: Implant, Intragastric For Morbid Obesity (LTI)
Published research
The most relevant PubMed records for "Lap-Band Adjustable Gastric"[tiab]. The summary above synthesizes these.
- A step-by-step guide to placement of the LAP-BAND adjustable gastric banding system.
Fielding GA, Allen JW · Am J Surg · 2002Review
- Lap Band adjustable gastric banding system: the Italian experience with 1863 patients operated on 6 years.
Angrisani L, Furbetta F, Doldi SB, et al. · Surg Endosc · 2003
- Prospective study of a laparoscopically placed, adjustable gastric band in the treatment of morbid obesity.
O'Brien PE, Brown WA, Smith A, et al. · Br J Surg · 1999
- Adjustable gastric banding: a comparison of models.
Ayloo SM, Fernandes E, Masrur MA, et al. · Surg Obes Relat Dis · 2014Comparative Study
- Variation in lipid levels in morbidly obese patients operated with the LAP-BAND adjustable gastric banding system: effects of different levels of weight loss.
Busetto L, Pisent C, Rinaldi D, et al. · Obes Surg · 2000
- Prospective study of 250 patients undergoing laparoscopic gastric banding using the two-step technique: a technique to prevent postoperative slippage.
Rubin M, Spivak H · Surg Endosc · 2003
- Treatment of Morbid Obesity Using an Adjustable Gastric Banding System.
Weiner R, Bockhorn H, Wagner D · Surg Technol Int · 2000
- Treatment of morbid obesity using an adjustable gastric banding system.
Weiner R, Bockhorn H, Wagner D · Surg Technol Int · 2000
- A prospective randomized trial of different laparoscopic gastric banding techniques for morbid obesity.
Weiner R, Bockhorn H, Rosenthal R, et al. · Surg Endosc · 2001Clinical Trial, Randomized Controlled Trial
Other devices of this type
Also filed under product code LTI.
- Obalon Balloon SystemMedtimo, Inc. · PMA 2022
- Orbera Intragastric BalloonBoston Scientific Corporation · PMA 2026
- Bioenterics Lap-Band Adjustable Gastric Banding SystemMedtimo, Inc. · PMA 2003
- ReShape Integrated Dual Balloon SystemBoston Scientific Corporation · PMA 2018
- Allurion Gastric Balloon SystemAllurion Technologies, Inc. · PMA 2026
- Spatz3 Adjustable Balloon SystemSpatz Fgia, Inc. · PMA 2023
- Ethicon Endo-Surgery Curved Adjustable Gastric with Sutureless Port and ApplierObtech Medical GmbH · PMA 2016
- Realize Adjustable Gastric BandObtech Medical GmbH · PMA 2011
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.